Skip to main content
Microbot Medical Inc. logo

Microbot Medical Inc. — Investor Relations & Filings

Ticker · MBOT ISIN · US59503A2042 LEI · 549300AEUNO16KTJXD72 US Manufacturing
Open in API
Filings indexed 1,061 across all filing types
Latest filing 2022-09-13 Regulatory Filings
Country US United States of America
Listing US MBOT

About Microbot Medical Inc.

http://www.microbotmedical.com/

Microbot Medical Inc. is a commercial-stage medical device company focused on transforming endovascular procedures with advanced robotic technology. The company researches, designs, and develops robotic endoluminal surgery devices for the minimally invasive surgery market. Its flagship product, the LIBERTY® Endovascular Robotic System, is the first single-use, remotely operated robotic solution designed to provide physicians with enhanced precision, control, and efficiency. Developed in collaboration with experts in Interventional Radiology, Neuroradiology, and Cardiology, the system aims to improve patient care and physician safety.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events or disclosures by a company. The text mentions a press release about the CEO presenting at an investment conference and includes a Regulation FD Disclosure. There is no detailed financial data or comprehensive report content such as an annual or quarterly report. The document is relatively short (4118 characters) and primarily serves to announce an event and provide a press release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2022-09-13 English
Regulatory Filings 2022
Regulatory Filings Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC by Microbot Medical Inc. It includes a Regulation FD Disclosure about the commencement of a GLP Pre-Clinical Trial for a robotic system and a press release as an exhibit. The document is short (3926 characters) and primarily serves to announce an event and furnish a press release, not to provide detailed financial data or a full report. It does not contain financial statements or substantive financial analysis. Therefore, it is a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into more specific categories like Annual Report, Earnings Release, or Capital Update.
2022-09-12 English
Board/Management Information 2022
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce specific events or disclosures that occur between periodic reports. The text includes a Regulation FD Disclosure about the appointment of a new member to the Scientific Advisory Board, which is a management or board-related announcement. There are no financial statements or detailed financial data present, and the document is relatively short (3856 characters). It is not an annual or quarterly report, earnings release, or any other detailed financial filing. The content fits best under Board/Management Information (MANG) as it announces a change/addition to the company's advisory board. Therefore, the classification is MANG with high confidence.
2022-09-08 English
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce specific events or disclosures. The text indicates it is a Regulation FD Disclosure about a patent grant and includes a press release as an exhibit. There are no financial statements or detailed financial data presented. The document is short (3934 characters) and primarily serves to announce an event rather than provide a full report or detailed financial information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2022-09-06 English
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Microbot Medical Inc. It includes a Regulation FD Disclosure about a press release related to a pre-clinical trial shipment and mentions the press release as Exhibit 99.1. The document is short (4164 characters) and primarily serves to announce the press release and provide regulatory disclosure rather than containing detailed financial data or comprehensive reports. There are no financial statements or detailed financial performance data included. This fits the profile of a Regulatory Filing (RNS), which is a general regulatory announcement and a fallback category for filings that do not fit other specific categories.
2022-09-02 English
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce specific events or disclosures. The text indicates that the company issued a press release about presenting a product at a conference, and the press release is furnished as an exhibit. There are no financial statements or detailed financial data included. The document is short (3868 characters) and primarily serves as a disclosure of a press release and event information. This fits the definition of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into more specific categories like earnings release or annual report.
2022-08-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.